Literature DB >> 10814581

Competitive binding to a charged leucine motif represses transformation by a papillomavirus E6 oncoprotein.

J Bohl1, K Das, B Dasgupta, S B Vande Pol.   

Abstract

E6 oncoproteins from HPV-16 and bovine papillomavirus type 1 (BPV-1) bind to similar leucine-rich peptides termed charged leucine motifs found on the cellular focal adhesion protein paxillin and the E3 ubiquitin ligase E6AP. BPV-1 E6 (BE6) mutants that do not bind to paxillin are defective at inducing cellular transformation. It is possible, however, that BE6 mutants that do not bind paxillin are defective for transformation for an unrelated reason than the ability to bind to charged leucine motifs. To address the role of BE6 interaction with charged leucine motifs, we fused a BE6-binding charged leucine motif to the amino terminus of BE6, thereby creating an autoinhibitory binding domain. We found that the fusion protein failed to bind to paxillin or transform murine C127 cells. Mutation of the amino terminal binding motif in the fusion protein restored both interaction with paxillin and transformation. This demonstrates that BE6 transformation requires binding to charged leucine motifs on particular cellular proteins and that transformation by papillomavirus oncoproteins can be repressed by competitive interactions with charged leucine motifs. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10814581     DOI: 10.1006/viro.2000.0316

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  25 in total

Review 1.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

2.  Transformation by bovine papillomavirus type 1 E6 requires paxillin.

Authors:  Ramon Wade; Nicole Brimer; Scott Vande Pol
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

Review 3.  Manipulation of Focal Adhesion Signaling by Pathogenic Microbes.

Authors:  Korinn N Murphy; Amanda J Brinkworth
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

4.  Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein.

Authors:  Nicole Brimer; Charles Lyons; Scott B Vande Pol
Journal:  Virology       Date:  2006-10-04       Impact factor: 3.616

5.  A mutant of human papillomavirus type 16 E6 deficient in binding alpha-helix partners displays reduced oncogenic potential in vivo.

Authors:  Marie Nguyen; Shiyu Song; Amy Liem; Elliot Androphy; Yun Liu; Paul F Lambert
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes.

Authors:  Regina B Park; Elliot J Androphy
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

7.  Proteomic analysis of the gamma human papillomavirus type 197 E6 and E7 associated cellular proteins.

Authors:  Miranda Grace; Karl Munger
Journal:  Virology       Date:  2016-10-20       Impact factor: 3.616

8.  Comprehensive analysis of host cellular interactions with human papillomavirus E6 proteins identifies new E6 binding partners and reflects viral diversity.

Authors:  Elizabeth A White; Rebecca E Kramer; Min Jie Alvin Tan; Sebastian D Hayes; J Wade Harper; Peter M Howley
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

9.  Cooperative transformation and coexpression of bovine papillomavirus type 1 E5 and E7 proteins.

Authors:  J Bohl; B Hull; S B Vande Pol
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

10.  Paxillin enables attachment-independent tyrosine phosphorylation of focal adhesion kinase and transformation by RAS.

Authors:  Ramon Wade; Nicole Brimer; Charles Lyons; Scott Vande Pol
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.